Abiopharma

FuelCell Energy Secures $49 Million in EXIM Financing to Advance U.S. Clean Energy Exports

Streamex Corp. Brings Yield-Bearing Gold (GLDY) to Traditional Brokerage Accounts Through Collaboration with Siebert Financial and tZERO

Almonty Industries Joins Large-Cap Russell 1000® Index and Broad-Market Russell 3000® Index

Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program

Twin Disc, Inc. Joins Russell 2000® and Russell 3000® Indexes

Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves Disease

Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations

Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease

HONEYWELL TECHNOLOGIES TO RELEASE SECOND QUARTER FINANCIAL RESULTS, DISCUSS 2026 OUTLOOK AND HOLD ITS INVESTOR CONFERENCE CALL ON THURSDAY, JULY 23

FreightCar America, Inc. Joins Russell 2000® and Russell 3000® Indexes